Colchicine poisoning
kol-chuh-seen poi-zuh-ning
Also known as: Colchicum autumnale toxicity, Meadow saffron poisoning
At a Glance
What is Colchicine poisoning?
Colchicine poisoning occurs when a person ingests a toxic dose of colchicine, a medication commonly used to treat gout. It primarily affects the gastrointestinal, cardiovascular, and hematological systems. The poisoning is caused by the disruption of cellular microtubule function, leading to cell death. Initially, symptoms may include nausea, vomiting, and diarrhea, progressing to multi-organ failure if untreated. Early symptoms are often gastrointestinal, while late symptoms can involve heart and bone marrow suppression. Early diagnosis is critical to prevent severe complications and improve outcomes. The condition can place a significant emotional and financial burden on families due to the need for intensive medical care. Prognosis depends on the dose ingested and the timeliness of treatment, with severe cases potentially being fatal. Daily life for survivors may involve ongoing medical monitoring and management of any organ damage sustained. Awareness and education about the risks of colchicine use are essential for prevention. Treatment often involves supportive care and, in some cases, specific antidotes. Understanding the signs of toxicity can lead to quicker intervention and better outcomes.
Colchicine poisoning Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Gastrointestinal distress manifests as severe abdominal pain, nausea, vomiting, and diarrhea. This occurs due to colchicine’s inhibition of mitosis in rapidly dividing cells of the gastrointestinal tract. Over time, these symptoms can lead to dehydration and electrolyte imbalances if not managed promptly. Patients may experience significant discomfort and disruption to daily activities, and treatment focuses on rehydration and symptomatic relief.
Multi-organ failure manifests as dysfunction in multiple body systems, including renal, hepatic, and cardiovascular systems. Colchicine disrupts cellular microtubule formation, leading to widespread cellular dysfunction. This condition can progress rapidly, leading to life-threatening complications if not addressed immediately. Patients require intensive medical intervention to support organ function and prevent irreversible damage.
Bone marrow suppression presents as a decrease in blood cell production, leading to anemia, leukopenia, and thrombocytopenia. Colchicine interferes with mitotic spindle formation, affecting rapidly dividing cells in the bone marrow. Over time, this can result in increased susceptibility to infections, fatigue, and bleeding tendencies. Patients may require blood transfusions and supportive care to manage these symptoms.
Common
Neuromuscular symptoms include muscle weakness, numbness, and tingling sensations. These occur due to colchicine's effects on microtubule function, impairing nerve signal transmission. Symptoms may worsen over time, leading to difficulty in performing daily tasks. Physical therapy and supportive care can help manage these symptoms.
Cardiovascular instability presents as hypotension, arrhythmias, and shock. Colchicine affects cardiac muscle cells and autonomic regulation, leading to these symptoms. Without prompt treatment, cardiovascular instability can lead to severe complications, including cardiac arrest. Management involves stabilization of cardiovascular function through medications and supportive care.
Fever is a common systemic response to colchicine poisoning, indicating an inflammatory reaction. It results from the release of pyrogens due to cellular damage and immune activation. Fever may persist or fluctuate, contributing to patient discomfort and dehydration. Antipyretics and hydration are typically used to manage this symptom.
Less Common
Hepatic dysfunction manifests as elevated liver enzymes, jaundice, and hepatic pain. Colchicine-induced cellular damage in the liver impairs its metabolic and detoxification functions. Over time, this can lead to more severe liver damage if not addressed. Monitoring liver function and providing supportive care are essential in managing this symptom.
Respiratory distress includes symptoms such as difficulty breathing, hypoxia, and pulmonary edema. Colchicine can affect respiratory muscles and lung tissue, leading to impaired respiratory function. This symptom can progress rapidly, requiring urgent medical intervention. Treatment focuses on ensuring adequate oxygenation and respiratory support.
What Causes Colchicine poisoning?
Colchicine poisoning is not caused by genetic mutations but rather by the ingestion of toxic doses of colchicine, a medication derived from the autumn crocus plant. Colchicine binds to tubulin, a protein that is crucial for microtubule formation, which is essential for cell division and intracellular transport. The binding of colchicine to tubulin disrupts microtubule polymerization, leading to impaired mitosis and cellular transport processes. This disruption causes a cascade of molecular events, including the inhibition of mitotic spindle formation, which ultimately results in cell cycle arrest and apoptosis. The impairment of microtubule function affects various organelles, such as the Golgi apparatus and endoplasmic reticulum, leading to cellular stress and dysfunction. Neighboring cells and tissues experience inflammation and damage due to the release of pro-inflammatory cytokines and cellular debris. The immune response is activated, leading to systemic inflammation and potentially contributing to multi-organ failure. Neuroinflammation may occur as a result of cytokine release and cellular damage, affecting the central nervous system. White matter degeneration is not a primary feature of colchicine poisoning, but neuronal damage can occur due to systemic toxicity. Symptoms appear in a specific pattern, starting with gastrointestinal distress, followed by multi-organ involvement, due to the widespread distribution of colchicine and its effects on rapidly dividing cells. The severity of colchicine poisoning varies between patients based on factors such as the dose ingested, individual metabolic differences, and the timeliness of medical intervention. Genetic factors do not play a direct role in colchicine poisoning, but variations in drug metabolism genes may influence individual susceptibility. The absence of a genetic basis for colchicine poisoning distinguishes it from hereditary diseases, focusing on the pharmacological and toxicological aspects of the drug. Understanding the cellular and systemic effects of colchicine is crucial for managing and treating poisoning cases effectively.
How is Colchicine poisoning Diagnosed?
Typical age of diagnosis: Colchicine poisoning can occur at any age, but it is often diagnosed in adults who have ingested the drug either accidentally or intentionally. Diagnosis typically occurs in the emergency setting when patients present with symptoms following colchicine exposure. Early recognition is crucial due to the rapid progression of toxicity. Diagnosis is confirmed through a combination of clinical evaluation, laboratory tests, and sometimes imaging studies.
Clinicians look for gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which are early signs of colchicine poisoning. A history of colchicine ingestion, including dose and time of ingestion, is critical. Physical examination may reveal signs of multi-organ dysfunction, including cardiovascular instability and neurological impairment. This step helps determine the severity of poisoning and guides immediate management.
Imaging modalities like abdominal X-rays or CT scans may be used to assess for complications such as bowel perforation. Specific abnormalities like bowel distension or free air may be visible, indicating severe gastrointestinal involvement. Imaging findings can support the diagnosis by correlating clinical symptoms with structural changes. Differential diagnoses such as other causes of acute abdomen can be excluded with imaging.
Laboratory tests include complete blood count, liver function tests, and renal function tests. Biomarkers such as elevated liver enzymes and creatinine indicate organ damage. Abnormal results, such as leukopenia and elevated transaminases, suggest colchicine toxicity. These results guide further management, including the need for intensive care monitoring.
Genetic testing is not typically used for diagnosing colchicine poisoning, as it is an acquired condition. However, in cases of familial Mediterranean fever, genes such as MEFV may be sequenced. Mutations in these genes can predispose individuals to colchicine use, but do not confirm poisoning. Genetic results can inform family counseling regarding the hereditary nature of predisposing conditions.
Colchicine poisoning Treatment Options
Activated charcoal is used as a gastrointestinal decontaminant. It works by adsorbing colchicine in the gastrointestinal tract, reducing systemic absorption. Clinical evidence supports its use if administered within one hour of ingestion. Limitations include reduced efficacy if administered late and potential for aspiration in patients with altered mental status. Side effects may include nausea and constipation.
Respiratory therapy techniques such as incentive spirometry and chest physiotherapy are used. The therapeutic goal is to prevent respiratory complications due to muscle weakness. Sessions are typically conducted daily, with duration adjusted based on patient response. Measurable outcomes include improved oxygenation and respiratory function. Long-term benefits include reduced risk of pneumonia and improved overall recovery.
Surgery may be indicated in cases of suspected bowel perforation. The procedure involves opening the abdominal cavity to identify and repair perforations. Expected benefits include resolution of peritonitis and prevention of sepsis. Surgical risks include infection, bleeding, and anesthesia complications. Post-operative care requires intensive monitoring and supportive care.
The care team typically includes intensivists, nurses, and pharmacists. Specific interventions include hemodynamic support, renal replacement therapy, and electrolyte management. Psychosocial support strategies involve counseling and communication with family members. Family education focuses on understanding the condition and its management. Long-term monitoring plans include regular follow-ups and assessment of organ function recovery.
When to See a Doctor for Colchicine poisoning
- Severe abdominal pain — this can indicate significant gastrointestinal distress or damage, requiring immediate medical attention.
- Difficulty breathing — this may suggest respiratory failure or severe systemic involvement, necessitating emergency care.
- Severe muscle weakness — this can be a sign of systemic toxicity affecting neuromuscular function, requiring urgent evaluation.
- Persistent nausea and vomiting — these symptoms can lead to dehydration and electrolyte imbalance; seek medical advice if they continue.
- Unexplained fever — this could indicate an infection or systemic inflammatory response; consult a healthcare provider.
- Unusual bruising or bleeding — this may suggest hematological complications; medical evaluation is recommended.
- Mild gastrointestinal upset — monitor for worsening symptoms and maintain hydration.
- Mild fatigue — ensure adequate rest and monitor for any progression of symptoms.
Colchicine poisoning — Frequently Asked Questions
Is this condition hereditary?
Colchicine poisoning is not hereditary as it results from exposure to the drug rather than genetic factors. There is no inheritance pattern or probability of passing it to children. De novo mutations do not occur in this context. Carrier status is not applicable as it is not a genetic condition. Genetic counseling is not required for colchicine poisoning.
What is the life expectancy for someone with this condition?
Life expectancy can vary significantly depending on the severity of poisoning and the timeliness of treatment. Early intervention and supportive care can improve outcomes and reduce mortality. Severe cases can lead to multi-organ failure, which is a common cause of mortality. Prompt treatment with activated charcoal and supportive measures can enhance survival chances. Realistic expectations depend on the dose ingested and the speed of medical response.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves clinical evaluation, history of colchicine exposure, and laboratory tests to assess organ function. The time from first symptoms to diagnosis can be rapid if there is a known exposure. Toxicologists and emergency medicine specialists are typically involved in the diagnosis. Delayed diagnosis can occur if the exposure history is unclear or symptoms are nonspecific. Confirmation is achieved through clinical presentation and laboratory findings.
Are there any new treatments or clinical trials available?
Research is ongoing into more effective antidotes and supportive therapies for colchicine poisoning. Novel approaches such as targeted therapies are being explored. ClinicalTrials.gov is a resource for finding current trials related to colchicine poisoning. Discuss potential participation in trials with your doctor to understand risks and benefits. New treatments may take years to become widely available, depending on trial outcomes.
How does this condition affect daily life and activities?
Colchicine poisoning can lead to temporary or prolonged physical weakness, affecting mobility and self-care. Educational activities may be disrupted due to hospital stays or recovery periods. Social and emotional challenges include anxiety and stress related to health concerns. Family members may experience increased caregiving responsibilities. Support from healthcare professionals and adaptations at home can aid recovery and improve quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Colchicine poisoning: the dark side of an ancient drug.
Finkelstein Y, Aks SE, Hutson JR et al. · Clin Toxicol (Phila) · 2010 · PMID: 20586571
- 2.Colchicine poisoning.
Hood RL · J Emerg Med · 1994 · PMID: 8207152
- 3.Progress in the management of acute colchicine poisoning in adults.
Wu J, Liu Z · Intern Emerg Med · 2022 · PMID: 36028733
- 4.Colchicine Poisoning: A Rare Case.
Amaral A, Ferreira da Silva D, Sampaio MB et al. · Cureus · 2023 · PMID: 38106754
- 5.Colchicine poisoning: Case report of three homicides in a family.
Liu YC, Zhou ZK, Yu MM et al. · Heliyon · 2024 · PMID: 38947441
- 6.Hematological aspects of colchicine poisoning.
Arnautou P, Bugier S · Blood · 2025 · PMID: 40705386
- 7.Colchicine Poisoning Cases in a Pediatric Intensive Care Unit: A Twenty-Year Study.
Süzen-Orhan E, Botan E, Gün E et al. · Pediatr Emerg Care · 2022 · PMID: 36018729
- 8.[Acute colchicine poisoning].
Sánchez Muñoz LA, Ferrero Beneítez O, Franco-Vicario R et al. · An Med Interna · 2000 · PMID: 10829476
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-21